shutterstock_605801525_rex_wholster
Rex Wholster / Shutterstock.com
15 April 2021GenericsAlex Baldwin

Fifth circuit denies Impax pay-for-delay petition

The Fifth Circuit of the Court of Appeals has denied a petition from  Impax Laboratories to overturn a decision finding Impax engaged in an illegal pay-for-delay settlement with Endo Pharmaceuticals.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Generics
27 May 2022   Why does Japan have no reverse payments culture? Takanori Abe of Abe & Partners unpicks a complex issue.
Big Pharma
5 June 2020   The advocate general has recommended that the Court of Justice of the European Union uphold an almost €94 million fine imposed on Lundbeck for its pay-for-delay scheme.
Americas
8 December 2014   A US court has spared drug companies AstraZeneca and Ranbaxy Laboratories a potentially hefty fine after ruling that a ‘pay-for-delay’ deal between them did not violate antitrust grounds.

More on this story

Generics
27 May 2022   Why does Japan have no reverse payments culture? Takanori Abe of Abe & Partners unpicks a complex issue.
Big Pharma
5 June 2020   The advocate general has recommended that the Court of Justice of the European Union uphold an almost €94 million fine imposed on Lundbeck for its pay-for-delay scheme.
Americas
8 December 2014   A US court has spared drug companies AstraZeneca and Ranbaxy Laboratories a potentially hefty fine after ruling that a ‘pay-for-delay’ deal between them did not violate antitrust grounds.

More on this story

Generics
27 May 2022   Why does Japan have no reverse payments culture? Takanori Abe of Abe & Partners unpicks a complex issue.
Big Pharma
5 June 2020   The advocate general has recommended that the Court of Justice of the European Union uphold an almost €94 million fine imposed on Lundbeck for its pay-for-delay scheme.
Americas
8 December 2014   A US court has spared drug companies AstraZeneca and Ranbaxy Laboratories a potentially hefty fine after ruling that a ‘pay-for-delay’ deal between them did not violate antitrust grounds.